Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Industry sponsor intelligence

Triastek (Shanghai) LimitedClinical Pipeline.

Lead-sponsor view of Triastek (Shanghai) Limited's indexed peptide studies, development phases, active programs, completed work and recent registry changes.

Total
1
Recruiting
0
Active
1
Completed
0
Results posted
0
Avg enrollment
18

Pipeline overview

Programs by phase and activity.

Velocity

Triastek (Shanghai) Limited trials by start year

Study start year · indexed snapshot

1110020262026: 1 trials

Development

Trials by phase

Early Phase 10
Phase 11
Phase 20
Phase 30
Phase 40
ProductStudiesEarly / IPhase IIPhase IIIPhase IVActive
Octreotide →110001

Active peptide trials

In motion now.

Completed trials

Finished registry records.

No studies in this snapshot.

Search sponsor records

All Triastek (Shanghai) Limited studies.

This page groups studies where Triastek (Shanghai) Limited is listed as the lead industry sponsor. Collaborator-only records are not included in the count.

1 matching study

End of 1 results

Recent updates

Latest registry movement.

NCT07663318A Phase 1 Study to Evaluate the Relative Bioavailability of Octreotide Acetate Tablets(T25) Compared to MYCAPSSA® and The Food Effect on Pharmacokinetics Of Octreotide Acetate Tablets(T25)Jun 29, 2026